| Autor: |
Hayriye Hizarcioglu-Gulsen, Ersin Gumus, Hulya Demir, Inci N. Saltik-Temizel, Ali Varan, Hilmi Anil Dincer, Ahmet Bulent Dogrul, Hasan Ozen |
| Rok vydání: |
2022 |
| Předmět: |
|
| Zdroj: |
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation. 20(Suppl 3) |
| ISSN: |
2146-8427 |
| Popis: |
Immunosuppressive therapy is a double-edged sword and causes a risk for some complications, such as opportunistic infections and posttransplant lymphoproliferative disease. The most likely risk factors for posttransplant lymphoproliferative disease are Epstein-Barr virus serology mismatch, prolonged and high viral load for Epstein-Barr virus, higher doses of immunosuppressive therapy, and cytomegalovirus infection. Transplant recipients who are seropositive for Epstein-Barr virus show a lower risk for posttransplant lymphoproliferative disease than seronegative recipients. Here, we present a 3.5-year-old boy who was seropositive for Epstein-Barr virus and developed posttransplant lymphoproliferative disease 18 months after liver transplant with a previous history of cytomegalovirus- related pneumatosis intestinalis. |
| Databáze: |
OpenAIRE |
| Externí odkaz: |
|
